ArticleThe Journal of international medical research2026
Perceptions regarding the use of cannabis in orthopaedics for treating musculoskeletal joint pain: A survey of arthritis patients.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is renewed interest in investigating the analgesic properties of cannabis for musculoskeletal joint pain; however, available data remain limited. This cross-sectional study was designed with the objective of evaluating patients' perceptions regarding the effect of cannabis on arthritis pain. Patients with arthritis pain presenting at one of three orthopedic clinics were asked to complete the study questionnaire. Outcomes were the perceived effect of cannabis on arthritic pain (measured using the continuous visual analog scale, with scores ranging from 0% to 100%) and association between preferences, attitudes, and barriers to the clinical use of cannabis for arthritic pain (evaluated using multivariable linear regression analyses). Sample size was also calculated using multivariable regression analysis. The study included 406 patients, including 105 (26.3%) who had already previously used cannabis for medical purposes and 63 (15.8%) who had used it during the past year. Approximately one-third of the patients who were prescribed opioids (78/256, 30.5%) had used them in the last week. On an average, patients stated that cannabis could treat 53.6% ± 2.6% of their pain (95% confidence interval = 51.1%-56.1%) and helped them replace 50.4% ± 3.2% of their analgesic medications (95% confidence interval = 47.2%-53.6%). Additionally, 88.8% of the patients (135/152) believed that cannabis would aid pain management. Individuals who had used cannabis for medical purposes (odds ratio = 7.2, 95% confidence interval = 1.6-12.8,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.